SureTrader Advertisement Advertisement Advertisement
Home > Boards > US Listed > Biotechs >

Alnylam Pharmaceuticals Inc. (ALNY)

Add ALNY Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator
Search This Board:
Last Post: 9/28/2015 7:41:19 PM - Followers: 21 - Board type: Free - Posts Today: 0 Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, engages in developing therapeutics based on RNA interference (RNAi). Its development programs include ALN-RSV01, a phase I human clinical trial product for the treatment of respiratory syncytial virus (RSV) infection; ALN-FLU01 for pandemic influenza; and ALN-PCS01 for the treatment of hypercholesterolemia with an RNAi therapeutic. The company also engages in pre-clinical discovery programs for RNAi therapeutics for the treatment of Parkinson's disease, Huntington's disease, neuropathic pain, progressive multifocal leukoencephalopathy, Ebola virus infection, and cystic fibrosis. It has strategic alliances with Merck & Co., Inc.; Medtronic, Inc.; and Novartis and Biogen Idec, Inc. for the development and commercialization of RNA interference system products. Alnylam also has contracts with government agencies, including the National Institute of Allergy and Infectious Diseases. In addition, it has license agreements with biotechnology companies, which engage in developing RNAi therapeutic products; and research companies that commercialize RNAi reagents or services. Further, the company has collaboration agreements with Medtronic, Inc. for the development of drug-device products to treat diseases caused by degeneration of the nervous system; and Biogen Idec, Inc. for research on the use of RNAi technology to discover and develop therapeutics to treat PML. It also has collaboration agreements with Novartis Pharma AG to develop RNAi therapeutics for pandemic flu; University of Texas Southwestern to develop RNAi therapeutics targeting proprotein convertase subtilisn/kexin type 9; and Inex Pharmaceuticals Corporation for the discovery, development, and commercialization of RNAi therapeutics. The company was founded in 2002 and is based in Cambridge, Massachusetts. Gallery View 4: (Full Sto, MACD, Aroon8)
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
ALNY News: Confidential Treatment Order (ct Order) 10/05/2015 04:21:03 PM
ALNY News: Current Report Filing (8-k) 10/02/2015 04:47:11 PM
ALNY News: Securities Registration: Employee Benefit Plan (s-8) 10/02/2015 04:32:51 PM
ALNY News: Alnylam & Genzyme Announce that Genzyme Opts into ALN-AT3 Hemophilia Program for Development & Commercialization Outside of N... 10/01/2015 07:00:00 AM
ALNY News: Alnylam Granted Summary Judgment by United States District Court for the District of Massachusetts in Tuschl II Patent Invent... 09/28/2015 02:47:00 PM
#180   Congrats on your plunge today great price you bigstocksnbonds 09/28/15 07:41:19 PM
#179   The options expired with full 100% profit. jrf30 09/28/15 07:38:49 PM
#178   Finally! Down to $84 now. Down jrf30 09/25/15 12:56:44 PM
#177   Last Friday it was at $109 3/4. jrf30 09/24/15 11:54:14 AM
#176   MDCO/ALNY—RNAi-based cholesterol drug shows durability: DewDiligence 08/30/15 12:56:43 PM
#175   Great way to buy it while limiting your bigstocksnbonds 08/24/15 11:59:07 AM
#174   Took the plunge. Sold some Sept 18th $90 jrf30 08/24/15 11:51:16 AM
#173   Selling some puts on this one may be bigstocksnbonds 08/22/15 04:36:08 PM
#172   I'm thinking of selling some puts on this jrf30 08/22/15 04:28:41 PM
#171   Yes it is looking better! May buy soon! bigstocksnbonds 08/07/15 07:24:26 PM
#170   It broke through 100 todAy. I'm still jrf30 08/07/15 06:56:30 PM
#169   It might be a bargain lower priced!! Thanks!! bigstocksnbonds 06/29/15 07:23:51 PM
#168   It hit $140 last Tuesday. Now the jrf30 06/29/15 03:40:10 PM
#167   Thank you much for your analysis on this bigstocksnbonds 06/10/15 08:48:36 PM
#166   I've done a lot of research over the jrf30 06/10/15 08:25:53 PM
#165   Would you advise taking a position here? Heard bigstocksnbonds 06/10/15 08:22:16 PM
#164   Its largely followed/traded by institutions. Not many here Kinny 06/09/15 08:26:19 AM
#163   The stock up SOO much in 2015, and jrf30 06/06/15 05:21:30 PM
#162   ALNY strong reversal as usual. Stock_Strategies 12/26/14 11:31:24 AM
#160   $ALNY DD Notes ~ stocktrademan 12/01/14 08:31:29 AM
#159   $ALNY DD Notes ~ stocktrademan 10/25/14 03:44:29 PM
#158   Good article for Alnylam (ALNY) "Alnylam Keeps Making BiotehPickList 10/14/14 02:27:52 PM
#157   Alnylam Initiates EXPLORE, a Prospective Observational Study of Wildbilly 10/01/14 10:51:49 PM
#156   The Second Coming of RNAi / The Scientist Wildbilly 10/01/14 10:44:57 PM
#155   New nanoparticles offer best-ever gene silencing, Wildbilly 02/11/14 06:10:05 PM
#154   RSI oversold here IMO sharky 02/06/14 10:29:42 AM
#153   Wow! Biotech investing can be so exhilarating! One Flap 01/13/14 10:29:57 AM
#152   8:00AM Alnylam Pharma presents new pre-clinical data on surf1944 12/19/13 11:20:34 AM
#151   8:07AM Alnylam Pharma initiates phase ii clinical trial surf1944 12/16/13 11:46:54 AM
#150   This is going to triple digits pete7 12/06/13 12:55:52 PM
#149   Very good article about RNAi therapeutics changing the Inoviorulez 11/05/13 05:18:02 PM
#148   7:02AM Alnylam Pharma reports positive clinical results -- surf1944 09/23/13 10:11:20 AM
#147   Looking good soon this will fly pete7 08/29/13 01:05:25 PM
#146   Interest points discussed at JMP Securities 2013 Healthcare Conference.... Nickw 07/23/13 09:07:41 AM
#145   8:01AM Alnylam Pharma presents key pre-clinical proof-of-concept data surf1944 05/17/13 11:39:23 AM
#144   Alnylam Pharmaceuticals' CEO Discusses Q4 2012 Results - surf1944 02/08/13 10:59:42 AM
#143   Will RGLS have any affect from ALNY shooting Gimmysomeofdat22 01/28/13 10:41:00 AM
#142   8:01AM Alnylam Pharma presents new pre-clinical data on surf1944 11/14/12 09:06:18 AM
#140   8:02AM Alnylam Pharma and collaborators publish new pre-clinical surf1944 08/22/12 09:18:26 AM
#139   I was a little early. Tim Lento 07/17/12 08:52:19 AM
#138   8:02AM Alnylam Pharma and Ascletis form strategic collaboration surf1944 07/12/12 09:50:02 AM
#137   ALNY Alnylam Receives Orphan Drug Designation from U.S. Pyckstocks 06/19/12 09:14:22 AM
#136   8:03AM Alnylam Pharma collaborators publish new pre-clinical results surf1944 06/12/12 10:09:05 AM
#135   8:02AM Alnylam initiates Phase II clinical trial of surf1944 06/07/12 09:05:48 AM
#134   Alnylam Pharma announces top-line results of Phase IIb mlkrborn 05/30/12 09:26:29 AM
#133   7:02AM Alnylam Pharma presents final results from a surf1944 05/10/12 08:25:33 PM
#132   Not even mentioned in the PR by ALNY urche 04/20/12 11:36:00 AM
#131   Alnylam Reports Positive Clinical Results for ALN-PCS, an surf1944 04/20/12 08:35:01 AM
#130   Future Trends In RNAi Drug Delivery surf1944 04/01/12 10:59:50 PM
#129   stox sale @10.75 mlkrborn 02/15/12 04:22:33 AM